|
IT1291892B1
(it)
|
1997-04-24 |
1999-01-21 |
Alessandro Lambiase |
Uso del nerve growth factor nella conservazione di cornee in coltura, nella produzione di tessuti corneali e congiuntivali in vitro e nella
|
|
ATE391492T1
(de)
|
1997-07-29 |
2008-04-15 |
Alcon Lab Inc |
Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat
|
|
IT1305294B1
(it)
|
1999-01-29 |
2001-05-04 |
Alessandro Lambiase |
Uso del nerve growth factor nella terapia di patologie a carico deitessuti intraoculari.
|
|
JP2002538124A
(ja)
|
1999-03-01 |
2002-11-12 |
ヴィスタ サイエンティフィック エルエルシー |
ムチンを含む眼科用調合物
|
|
WO2002049611A2
(en)
*
|
2000-12-20 |
2002-06-27 |
Alcon, Inc. |
Ophthalmic lubricating solution adapted for use in lasik surgery
|
|
US6878694B2
(en)
|
2000-12-20 |
2005-04-12 |
Alcon, Inc. |
Ophthalmic irrigating solution adapted for use in lasik surgery
|
|
US7544348B2
(en)
*
|
2001-02-15 |
2009-06-09 |
Access Pharmaceuticals, Inc. |
Liquid formulations for the prevention and treatment of mucosal diseases and disorders
|
|
ES2314049T3
(es)
*
|
2001-02-15 |
2009-03-16 |
Access Pharmaceuticals, Inc. |
Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa.
|
|
US6465506B2
(en)
*
|
2001-02-22 |
2002-10-15 |
Ophthalmic Research Associates, Inc. |
Instillation techniques for ophthalmic agents to enhance treatment effect
|
|
CA2447383A1
(en)
|
2001-06-29 |
2003-01-09 |
Biovitrum Ab |
Process for bulk autoclaving
|
|
WO2003013612A1
(fr)
*
|
2001-08-10 |
2003-02-20 |
Toray Industries, Inc. |
Compositions contenant du polysaccharide et leur utilisation
|
|
US20040220089A1
(en)
*
|
2001-10-03 |
2004-11-04 |
Ellis Edward J. |
Ophthalmic preparation containing glycoprotein
|
|
US20040214754A1
(en)
*
|
2001-10-03 |
2004-10-28 |
Ellis Edward J. |
Ophthalmic preparation containing glycomacropeptide
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
EP2130541A3
(en)
|
2002-07-29 |
2013-12-18 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
|
|
US6984628B2
(en)
*
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
|
US20050113398A1
(en)
|
2003-08-07 |
2005-05-26 |
Ankush Argade |
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
|
|
AU2004263149B2
(en)
*
|
2003-08-07 |
2010-08-19 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using same
|
|
WO2005039640A1
(en)
*
|
2003-10-03 |
2005-05-06 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
|
|
EP1683528A4
(en)
*
|
2003-11-10 |
2011-07-27 |
Toray Industries |
POLYSACCHARIDE-CONTAINING COMPOSITION AND OPHTHALMIC SOLUTION FOR STABILIZING THE TISSUE FILM
|
|
US20050210732A1
(en)
*
|
2004-03-26 |
2005-09-29 |
Guerin John W |
Crank bait tail
|
|
JP4395016B2
(ja)
*
|
2004-06-29 |
2010-01-06 |
日清オイリオグループ株式会社 |
ゲル状吸水用組成物
|
|
ATE429209T1
(de)
†
|
2005-02-09 |
2009-05-15 |
Safilens S R L |
Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
|
|
PL1698630T3
(pl)
|
2005-03-03 |
2014-12-31 |
Alfasigma Spa |
Nowe postacie polimorficzne rifaksyminy,sposoby ich wytwarzania i ich zastosowanie w preparatach leczniczych
|
|
ITBO20050388A1
(it)
*
|
2005-06-06 |
2006-12-07 |
Alfa Wassermann Spa |
Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
|
|
ITRM20050447A1
(it)
*
|
2005-08-19 |
2007-02-20 |
Anabasis S R L |
Uso del nerve growth factor in collirio nella terapia di patologie del sistema nervoso centrale, quali la malattia di alzheimer e il morbo di parkinson.
|
|
CA2642229C
(en)
|
2006-02-24 |
2015-05-12 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
JP5134778B2
(ja)
*
|
2006-03-10 |
2013-01-30 |
日清オイリオグループ株式会社 |
ゲル組成物及び該ゲル組成物を使用したパック化粧料
|
|
EP2078026B1
(en)
|
2006-11-21 |
2012-01-04 |
Rigel Pharmaceuticals, Inc. |
Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses
|
|
ITRM20070510A1
(it)
*
|
2007-10-02 |
2009-04-03 |
Rmfa Trading S A |
Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
|
|
GB0719969D0
(en)
|
2007-10-12 |
2007-11-21 |
Cambridge Entpr Ltd |
Substance monitoring and control in human or animal bodies
|
|
AU2008350907A1
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
US7842714B2
(en)
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
|
WO2010078369A2
(en)
|
2008-12-30 |
2010-07-08 |
Rigel Pharmaceuticals, Inc. |
Pyrimidinediamine kinase inhibitors
|
|
SI2565193T1
(sl)
|
2009-01-23 |
2014-07-31 |
Rigel Pharmaceuticals, Inc. |
Sestavki in metode inhibicije JAK poti
|
|
CN102405044A
(zh)
|
2009-02-06 |
2012-04-04 |
南加利福尼亚大学 |
含有单萜的治疗组合物
|
|
CN106420756A
(zh)
|
2009-07-28 |
2017-02-22 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
IT1396607B1
(it)
*
|
2009-11-16 |
2012-12-14 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
|
|
IT1397132B1
(it)
|
2009-12-01 |
2013-01-04 |
Alfa Wassermann Spa |
Composizioni comprendenti antiinfiammatori non steroidei.
|
|
WO2011109635A1
(en)
|
2010-03-03 |
2011-09-09 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
|
RS55010B1
(sr)
|
2010-04-24 |
2016-11-30 |
Viamet Pharmaceuticals Inc |
Jedinjenja koja inhibiraju metaloencime
|
|
ES2635169T3
(es)
|
2010-05-24 |
2017-10-02 |
Indena S.P.A. |
Polisacárido de semillas de tamarindo y extracto de Ferula hermonis para uso en el tratamiento de enfermedades inflamatorias
|
|
KR101878450B1
(ko)
|
2010-05-24 |
2018-07-13 |
인데나 에스.피.에이 |
미생물 감염의 치료에서의 사용을 위한 타마린드 씨 다당류
|
|
JP5620168B2
(ja)
*
|
2010-06-30 |
2014-11-05 |
Ｄｓｐ五協フード＆ケミカル株式会社 |
キシログルカン−カチオン複合体及びそれを含有する安定化組成物
|
|
BR112012011818B1
(pt)
*
|
2010-07-12 |
2020-11-24 |
Zambon S.P.A. |
Preparação na forma de uma dosagem liquida para aplicaqao topica aerossolizada
|
|
PL2598500T3
(pl)
|
2010-07-28 |
2021-11-29 |
Rigel Pharmaceuticals, Inc. |
Kompozycje i sposoby hamowania szlaku JAK
|
|
CN105078973B
(zh)
|
2010-08-27 |
2020-10-09 |
尼昂克技术公司 |
包含poh衍生物的药物组合物
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
JP5921560B2
(ja)
|
2010-10-28 |
2016-05-24 |
イノクリン ファーマシューティカルズ，インコーポレイテッド |
金属酵素阻害化合物
|
|
EA024197B1
(ru)
|
2010-11-13 |
2016-08-31 |
Иннокрин Фармасьютикалс, Инк. |
Соединения, ингибирующие металлоферменты
|
|
EP3130579B1
(en)
|
2010-12-17 |
2024-02-07 |
University of Southern California |
Conjugates of isoperillyl alcohol
|
|
CA2828360A1
(en)
|
2011-02-25 |
2012-08-30 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Chrysophaentin analogs that inhibit ftsz protein
|
|
ITMI20110583A1
(it)
|
2011-04-08 |
2012-10-09 |
Hmfra Hungary Ltd Liability Company |
Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
|
|
RU2463022C1
(ru)
*
|
2011-04-19 |
2012-10-10 |
Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" |
Способ лечения больных с синдромом "сухого глаза"
|
|
CN103608028A
(zh)
|
2011-04-28 |
2014-02-26 |
南加利福尼亚大学 |
人类髓源抑制性细胞癌症标记
|
|
IN2014MN00093A
(it)
|
2011-06-19 |
2015-06-19 |
Viamet Pharmaceuticals Inc |
|
|
US8796001B2
(en)
|
2011-06-19 |
2014-08-05 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2012177728A1
(en)
|
2011-06-23 |
2012-12-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
ES2541761T3
(es)
*
|
2011-08-12 |
2015-07-24 |
Zambon S.P.A. |
Utilización de un polímero polisacárido procedente de las semillas del árbol tamarindo para la protección frente a los daños asociados al tabaco
|
|
WO2013035837A1
(ja)
*
|
2011-09-07 |
2013-03-14 |
千寿製薬株式会社 |
水性液剤の粘度低下抑制方法
|
|
WO2013046059A2
(en)
*
|
2011-09-27 |
2013-04-04 |
Sykora Robert C |
Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
|
|
SI2788343T1
(sl)
|
2011-12-11 |
2019-09-30 |
Viamet Pharmaceuticals (NC), Inc. |
Spojine inhibitorja metaloencimov
|
|
ES2774267T3
(es)
|
2012-01-20 |
2020-07-20 |
Mycovia Pharmaceuticals Inc |
Compuestos inhibidores de metaloenzimas
|
|
EP2828241B1
(en)
|
2012-03-23 |
2018-09-12 |
Mateon Therapeutics, Inc. |
Compositions and methods for inhibition of cathepsins
|
|
WO2013173506A2
(en)
|
2012-05-16 |
2013-11-21 |
Rigel Pharmaceuticals, Inc. |
Method of treating muscular degradation
|
|
EP3016634A2
(en)
*
|
2013-07-05 |
2016-05-11 |
Therakine Biodelivery GmbH |
Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition
|
|
EP2883931A1
(en)
*
|
2013-12-12 |
2015-06-17 |
Omya International AG |
Improved gel stability
|
|
ES2750152T3
(es)
|
2014-04-15 |
2020-03-25 |
Devintec Sagl |
Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
|
|
US11623008B2
(en)
*
|
2014-08-20 |
2023-04-11 |
Professional Compounding Centers Of America |
Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
|
|
EP3261441B1
(en)
|
2015-02-12 |
2020-09-09 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
|
EP3103438B1
(en)
|
2015-06-11 |
2018-11-14 |
Novintethical Pharma SA |
Topical nasal compositions containing xyloglucans for use as decongestans
|
|
SG10201913468YA
(en)
*
|
2015-07-13 |
2020-03-30 |
Tohoku Techno Arch Co Ltd |
Composition for optic nerve protection
|
|
DK3331879T3
(da)
|
2015-08-04 |
2020-08-10 |
Rigel Pharmaceuticals Inc |
Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
|
|
WO2017025983A1
(en)
|
2015-08-07 |
2017-02-16 |
Council Of Scientific & Industrial Research |
A lubricant formulation of carbamoylethyl katira and a process for preparation thereof
|
|
EP3397629B1
(en)
|
2015-12-30 |
2023-04-19 |
NQP 1598, Ltd. |
Metalloenzyme inhibitor compounds
|
|
ES2940911T3
(es)
|
2016-06-27 |
2023-05-12 |
Rigel Pharmaceuticals Inc |
Compuestos de 2,4-diamino-pirimidina y su uso como inhibidores de IRAK4
|
|
WO2018081294A1
(en)
|
2016-10-26 |
2018-05-03 |
Rigel Pharmaceuticals, Inc. |
Pyrazole amide compounds as irak inhibitors
|
|
PT3532470T
(pt)
|
2016-10-26 |
2023-02-28 |
Rigel Pharmaceuticals Inc |
Derivados de oxazol para uso como inibidores de irak e método para a sua preparação
|
|
CN110267538B
(zh)
|
2016-11-30 |
2022-04-19 |
尼昂克技术公司 |
紫苏醇-3-溴丙酮酸缀合物和治疗癌症的方法
|
|
WO2018125799A2
(en)
|
2016-12-29 |
2018-07-05 |
Viamet Pharmaceuticals (Bermuda), Ltd. |
Metalloenzyme inhibitor compounds
|
|
EP4311577A3
(en)
|
2016-12-29 |
2024-04-17 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
EP3645525A1
(en)
|
2017-06-29 |
2020-05-06 |
Rigel Pharmaceuticals, Inc. |
Kinase inhibitors and methods for making and using
|
|
US11129862B2
(en)
*
|
2017-08-30 |
2021-09-28 |
Johnson & Johnson Consumer Inc. |
Ophthalmic compositions
|
|
US20210292410A1
(en)
|
2017-12-07 |
2021-09-23 |
Morphosys Ag |
Treatment paradigm for an anti-cd19 antibody and venetoclax combination treatment
|
|
WO2019157195A1
(en)
|
2018-02-08 |
2019-08-15 |
Neonc Technologies, Inc |
Methods of permeabilizing the blood brain barrier
|
|
BR112020022423A2
(pt)
|
2018-05-03 |
2021-02-02 |
Rigel Pharmaceuticals, Inc. |
composto, composição farmacêutica, método, método para tratar uma doença em um indivíduo e método para fabricar o composto
|
|
RS64736B1
(sr)
|
2018-05-03 |
2023-11-30 |
Rigel Pharmaceuticals Inc |
Jedinjenja inhibitori rip1 i postupci za njihovo dobijanje i upotrebu
|
|
US20220000880A1
(en)
|
2018-11-01 |
2022-01-06 |
Rigel Pharmaceuticals, Inc. |
Method and composition embodiments for treating acute myeloid leukemia
|
|
JP2022516969A
(ja)
|
2019-01-08 |
2022-03-03 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
金属酵素阻害剤化合物
|
|
WO2020243612A1
(en)
|
2019-05-29 |
2020-12-03 |
Rigel Pharmaceuticals, Inc. |
Method of preventing and treating thrombosis
|
|
MX2022001596A
(es)
|
2019-08-08 |
2022-03-11 |
Rigel Pharmaceuticals Inc |
Compuestos y metodos para tratar sindrome de liberacion de citocinas.
|
|
ES2970382T3
(es)
|
2019-08-14 |
2024-05-28 |
Rigel Pharmaceuticals Inc |
Método para bloquear o mejorar el síndrome de liberación de citocinas
|
|
AU2020335903A1
(en)
|
2019-08-30 |
2022-03-24 |
Rigel Pharmaceuticals, Inc. |
Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
|
|
EP4025568B1
(en)
|
2019-09-06 |
2025-05-14 |
Rigel Pharmaceuticals, Inc. |
Rip1 inhibitory compounds and methods for making and using the same
|
|
US11564930B2
(en)
|
2019-09-06 |
2023-01-31 |
Rigel Pharmaceuticals, Inc. |
RIP1 inhibitory compounds and methods for making and using the same
|
|
IL292536A
(en)
|
2019-11-07 |
2022-06-01 |
Rigel Pharmaceuticals Inc |
Heterocyclic compounds inhibit rip1
|
|
US12357623B2
(en)
|
2021-03-03 |
2025-07-15 |
Rigel Pharmaceuticals, Inc. |
Method for treating a disease or condition using a pyrazole compound or formulation thereof
|
|
AR125587A1
(es)
|
2021-03-11 |
2023-08-02 |
Rigel Pharmaceuticals Inc |
Inhibidores heterocíclicos de la quinasa de rip1
|
|
JP2025513716A
(ja)
|
2022-03-23 |
2025-04-30 |
ライジェル・ファーマシューティカルズ・インコーポレイテッド |
Ｉｒａｋ阻害剤としてのピリミド－２－イル－ピラゾール化合物
|
|
US12459941B2
(en)
|
2022-03-31 |
2025-11-04 |
Rigel Pharmaceuticals, Inc. |
Tricyclic IRAK inhibitors
|
|
WO2024201425A1
(en)
*
|
2023-03-31 |
2024-10-03 |
Procyto Labs Pvt Ltd. |
Preservative-free allergen blocker eye gel
|